Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
12.91
-0.36 (-2.71%)
Mar 9, 2026, 3:04 PM CST
19.65%
Market Cap 13.38B
Revenue (ttm) 5.22B
Net Income (ttm) 407.37M
Shares Out 1.04B
EPS (ttm) 0.34
PE Ratio 38.00
Forward PE 25.31
Dividend 0.10 (0.75%)
Ex-Dividend Date May 29, 2025
Volume 19,860,550
Average Volume 20,440,466
Open 13.14
Previous Close 13.27
Day's Range 12.82 - 13.16
52-Week Range 9.98 - 16.66
Beta 0.90
RSI 62.09
Earnings Date Apr 24, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.